Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Washington Drug Letter > Senators Revive Direct Negotiation on Drug Prices in Medicare

Washington Drug Letter

Aug. 1, 2011 | Vol. 43 No. 30

Senators Revive Direct Negotiation on Drug Prices in Medicare

A Senate committee is bringing back the idea of direct price negotiation between Medicare and pharma companies.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

Expert: FDA May Have Slowed GDUFA Ramp-Up to Prep for Sequestration Senate Bill Would Ban Pay-for-Delay Deals Bill: Generic Opioids Must Mimic Abuse-Deterrent Features Legislative Actions

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.